help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henry, H. L.
Right arrow Articles by Luntao, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henry, H. L.
Right arrow Articles by Luntao, E. M.

Endocrinology, Vol 124, 2228-2234, Copyright © 1989 by Endocrine Society


ARTICLES

Interactions between intracellular signals involved in the regulation of 25-hydroxyvitamin D3 metabolism

HL Henry and EM Luntao
Department of Biochemistry, University of California, Riverside 92521.

The tumor-promoting phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) increases 25-hydroxyvitamin D3 (25OHD3)-24-hydroxylase and decreases 25OHD3-1-hydroxylase activity in cultured kidney cells, effects similar to those exerted by 1,25-dihydroxyvitamin D3 [1,25- (OH)2D3] and opposite those of PTH, forskolin, and cAMP. In this paper it is shown that the effects of TPA and 1,25-(OH)2D3 are additive, suggesting that they operate through distinct mechanisms. TPA did not alter cAMP metabolism by cultured chick kidney cells, not did it alter their response, in terms of 25OHD3 metabolism, to cAMP, suggesting that these two regulators of 25OHD3 metabolism also operate through distinct pathways. Another presumed activator of protein kinase-C 1,oleoyl-2- acetyl-glycerol, was tested and found to have the same effect as TPA in decreasing 1-hydroxylase activity, but it does not increase 24- hydroxylase activity. In addition, 1-oleoyl-2-acetyl-glycerol increases intracellular cAMP levels to approximately 25% of those attained by stimulation with PTH. None of the treatments resulted in altered [3H]PDBu binding by the cells. The results, taken together, suggest that 25OHD3-1-hydroxylase and the 25OHD3-24-hydroxylase are subject to multifactorial regulation and can be regulated independently of one another.


This article has been cited by other articles:


Home page
EndocrinologyHome page
R. Bland, E. A. Walker, S. V. Hughes, P. M. Stewart, and M. Hewison
Constitutive Expression of 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase in a Transformed Human Proximal Tubule Cell Line: Evidence for Direct Regulation of Vitamin D Metabolism by Calcium
Endocrinology, May 1, 1999; 140(5): 2027 - 2034.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Yang, P. A. Friedman, R. Kumar, J. L. Omdahl, B. K. May, M.-L. Siu-Caldera, G. S. Reddy, and S. Christakos
Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH
Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E793 - E805.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. J. Armbrecht, T. L. Hodam, M. A. Boltz, N. C. Partridge, A. J. Brown, and V. B. Kumar
Induction of the Vitamin D 24-Hydroxylase (CYP24) by 1,25-Dihydroxyvitamin D3 Is Regulated by Parathyroid Hormone in UMR106 Osteoblastic Cells
Endocrinology, August 1, 1998; 139(8): 3375 - 3381.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Menaa, F.ço. Vrtovsnik, Gér. Friedlander, M. Corvol, and M.èl. Garabédian
Insulin-like Growth Factor I, a Unique Calcium-dependent Stimulator of 1,25-Dihydroxyvitamin D(3) Production
J. Biol. Chem., October 27, 1995; 270(43): 25461 - 25467.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society